Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
Stock prices of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) saw a one year low price reaching $47.07 on Wednesday. Shares ended down moving 1.0226% with the final trade at $47.67. 619,259 shares were bought and sold and the stock hit a high of $48.48 during trading.
The stock ended the day at $47.67 a bit lower than $51.24, the 50 day moving average and just a bit lower than the 200 day moving average of $55.28. The 50 day moving average went down $-3.58 or -6.9766% and the 200 day average was down $-7.61.
The most current P/E ratio is 25.4634 and market capitalization is 4.17B. In the latest earnings report the EPS was $1.87 and is estimated to be $2.64 for the current year with 87,416,000 shares presently outstanding. Next quarter’s EPS is expected be $0.70 and the next full year EPS is anticipated to be $3.16.
Traders are a little more bullish on the company lately as inferred by the motion in short interest. The stock saw a fall in short interest of -0.01% as of September 15, 2016 from the last reporting period. Short interest fell 56,765 over that period. The short-interest ratio decreased to 12.0 and the short interest percentage is 0.12% as of September 15.
Wall Street investment firms have released opinions. On February 17 Avondale Partners left the stock rating at “Market Outperform” but moved down the price target from $90.00 to $71.00. On February 1, 2016 KeyBanc added the stock to its research portfolio by announcing an initial rating of “Overweight” and projecting a price target of $85.00.
On September 16 analysts at JP Morgan issued its first research report on the stock giving it an initial rating of “Neutral”. Equity analyst Leerink Swann initiated coverage on the stock with a rating of “Outperform” and setting a price target of $90.00.
Mizuho Securities released its first research report on the stock setting a rating of “Buy” and establishing a price target of $84.00. May 21 investment analysts at Susquehanna maintained a company rating of “Positive” but raised the price target to $83.00 from $75.00.